Wall Street Zen Downgrades Bioceres Crop Solutions (NASDAQ:BIOX) to Sell

Key Points

• Bioceres Crop Solutions has been downgraded from a "hold" rating to a "sell" rating by Wall Street Zen, reflecting a significant shift in analyst sentiment.
• Canaccord Genuity lowered their price target for the company's shares from $6.50 to $2.50, indicating a decrease in expected stock performance.
• Currently, the stock has a consensus rating of "Moderate Buy" with an average price target of $4.17, suggesting mixed opinions among analysts.

Wall Street Zen cut shares of Bioceres Crop Solutions (NASDAQ:BIOX - Free Report) from a hold rating to a sell rating in a report issued on Saturday morning.

Other research analysts also recently issued reports about the company. Oppenheimer set a $5.00 price target on Bioceres Crop Solutions in a report on Tuesday, September 9th. Brookline Capital Management downgraded Bioceres Crop Solutions from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 21st. Lake Street Capital dropped their price target on Bioceres Crop Solutions from $8.00 to $5.00 and set a "buy" rating on the stock in a research note on Wednesday, September 10th. Finally, Canaccord Genuity Group reissued a "hold" rating and issued a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday, September 10th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $4.17.

Bioceres Crop Solutions Price Performance

Bioceres Crop Solutions stock traded down $0.04 during midday trading on Friday, reaching $1.77. 879,930 shares of the stock traded hands, compared to its average volume of 584,111. The stock's fifty day moving average is $3.06 and its 200-day moving average is $4.02. Bioceres Crop Solutions has a 12 month low of $1.76 and a 12 month high of $8.79. The stock has a market cap of $111.00 million, a P/E ratio of -2.19 and a beta of 0.43. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.22.

Institutional Trading of Bioceres Crop Solutions

Hedge funds and other institutional investors have recently bought and sold shares of the business. Jones Financial Companies Lllp increased its position in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock worth $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE increased its position in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after purchasing an additional 3,735 shares during the period. Avanza Fonder AB purchased a new stake in shares of Bioceres Crop Solutions during the 1st quarter worth approximately $72,000. PDT Partners LLC purchased a new stake in shares of Bioceres Crop Solutions during the 1st quarter worth approximately $81,000. Finally, Northern Trust Corp purchased a new stake in Bioceres Crop Solutions in the 4th quarter valued at approximately $93,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.